Transnasal Endoscopic Pituitary Surgery - the Effect of Posterior Nasal Septum Resection on Nasal Functions
NCT04782596 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2022-12-07
Summary
The aim of the project is to compare the effect of different extent of resection of the posterior part of the septum on the postoperative nasal functions.
Conditions
- Pituitary Adenoma
Interventions
- PROCEDURE
-
Posterium nasal septum resection
Posterium nasal septum resection is required to ensure approach during transnasal endoscopic pituitary surgery in patients with pituitary adenoma.
Sponsors & Collaborators
-
University Hospital Ostrava
lead OTHER
Principal Investigators
-
Jakub Lubojacký, MD · University Hospital Ostrava
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-01
- Primary Completion
- 2022-01-31
- Completion
- 2022-01-31
Countries
- Czechia
Study Locations
More Related Trials
-
Intraoperative Ultrasound in Patients Undergoing Transsphenoidal Surgery for Pituitary Adenoma
NCT03284775 ·Status: COMPLETED ·Phase: NA
-
Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment
NCT00647179 ·Status: COMPLETED
-
Preoperative Octreotide Treatment of Acromegaly
NCT00521300 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
NCT07335315 ·Status: RECRUITING
-
Follow-up Evaluation of Photo-Dynamic Therapy for Pituitary Tumours
NCT02632084 ·Status: COMPLETED
-
Intraoperative Imaging of Pituitary Adenomas by OTL
NCT02629549 ·Status: TERMINATED ·Phase: PHASE1
-
Next Day Growth Hormone Predicting Pituitary Function After Adenomectomy
NCT03708523 ·Status: UNKNOWN
-
Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease
NCT04339751 ·Status: WITHDRAWN ·Phase: PHASE2
-
Long Term Outcome Study in Patients With Pituitary Disorders
NCT03665064 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases
NCT06435195 ·Status: RECRUITING
-
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
NCT00001595 ·Status: RECRUITING
-
The Observational Study of Growth Hormone-secreting Pituitary Tumors
NCT01368133 ·Status: UNKNOWN
-
Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas
NCT00929669 ·Status: TERMINATED ·Phase: PHASE2
-
The Treatment and Natural History of Acromegaly
NCT00001981 ·Status: COMPLETED
-
Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome
NCT02705014 ·Status: UNKNOWN ·Phase: NA
-
DDAVP for Pituitary Adenoma
NCT04569591 ·Status: RECRUITING ·Phase: NA
-
Cabergoline in Nonfunctioning Pituitary Adenomas
NCT03271918 ·Status: COMPLETED ·Phase: PHASE3
-
Age-related Differences in Response to Pituitary Stimulation Tests
NCT04572139 ·Status: COMPLETED
-
Posttraumatic Hypopituitarism - Incidence, Predictors and Test Validity
NCT01028742 ·Status: COMPLETED
-
Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions
NCT02190994 ·Status: UNKNOWN ·Phase: PHASE4
-
Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors
NCT06679816 ·Status: RECRUITING ·Phase: PHASE4
-
Octreotide Efficacy and Safety in First-line Acromegalic Patients
NCT00171886 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma.
NCT01283542 ·Status: COMPLETED ·Phase: PHASE2
-
Study on Therapy of Non-invasive Prolactinoma
NCT03353025 ·Status: RECRUITING ·Phase: NA
-
The TMS Treatment for Postoperative Headache in GH Tumor
NCT04529356 ·Status: UNKNOWN ·Phase: NA